U.S. market Closed. Opens in 17 hours 13 minutes

PTGX | Protagonist Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue60.00M26.58M27.36M28.63M231.00K30.93M20.06MN/AN/AN/A
Cost of Revenue3.31M1.03M2.77MN/AN/AN/AN/AN/AN/AN/A
Gross Profit56.69M25.55M24.58M28.63M231.00K30.93MN/AN/AN/AN/A
Operating Expenses153.65M157.95M153.20M93.14M80.75M73.19M57.96M32.67MN/AN/A
Selling, General & Admin33.49M31.74M27.20M18.64M15.75M13.70M11.78M6.96M2.96M1.86M
Research & Development120.16M126.22M126.01M74.51M65.00M59.50M46.18M25.70M11.83M7.46M
Other Operating Expenses-201.00K-80.00K-149.00K-46.00K-1.00KN/AN/AN/AN/AN/A
Operating Income-93.65M-131.37M-125.84M-64.52M-80.52M-42.27M-37.90M-32.67M-14.79M-9.32M
Other Expenses / Income-201.00K3.98M294.00K-329.00K2.64M2.55M940.00K-4.51M-64.00K-1.75M
Before Tax Income-78.95M-127.39M-125.55M-64.84M-77.88M-39.72M-36.96M-37.18M-14.86M-11.07M
Income Tax Expenses-14.90M-3.98M-2.92M1.30M-691.00K-799.00KN/AN/AN/AN/A
Net Income-78.95M-123.41M-122.63M-66.15M-77.19M-38.92M-36.96M-37.18M-14.86M-11.07M
Interest ExpensesN/A-3.37MN/A598.00K169.00KN/AN/AN/AN/AN/A
Basic Shares Outstanding56.76M49.04M46.32M34.40M25.89M22.36M17.69M6.50M4.31M5.88M
Diluted Shares Outstanding56.76M49.04M46.32M34.40M25.89M22.36M17.69M6.50M4.31M5.88M
EBITDA-90.34M-131.37M-125.55M-63.66M-77.71M-42.27M-36.55M-32.35M-14.46M-7.29M
EBITDA Margin-150.57%-494.24%-458.94%-222.38%-33,640.26%-136.68%-182.18%0.00%0.00%0.00%
EBIT-93.85M-130.76M-125.55M-64.25M-77.71M-39.72M-36.96M-37.18M-14.86M-11.07M
EBIT Margin-156.42%-491.94%-458.94%-224.42%-33,640.26%-128.45%-184.20%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙